Navigation Links
Canadian synchrotron conference sheds light on new biomedical research
Date:6/15/2009

Science fact surpasses science fiction at the Canadian Light Source (CLS) synchrotron's 12th Annual Users' Meeting Thursday, June 18 at the Radisson Hotel in Saskatoon. Conference participants will hear about some of the newest biomedical results from the CLS, as well as ways that synchrotron techniques are lighting the way to advances in environmental clean up and nanotechnology.

Highlights include:

  • Presentations by CLS users on using the synchrotron to study esophageal tumours, prion diseases such as BSE, watch nerves regenerate and treat tuberculosis
  • Applications of synchrotron techniques to agricultural research, developing bioproducts and bioremediation
  • Studying nanomaterials and materials at extreme conditions

Science fact is preceded by a free public lecture "Science Fiction as a Mirror for Reality" by internationally renowned science fiction author and CLS writer-in-residence Robert J. Sawyer on Wednesday, June 17 at 7 pm at the Frances Morrison Library Theatre.


'/>"/>

Contact: Matthew Dalzell
matt.dalzell@lightsource.ca
306-657-3739
Canadian Light Source, Inc.
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. University of Saskatchewan and Canadian Synchrotron researchers shed light on esophageal disease
2. Canadian-based UN coral reef expert honored at world meeting in Australia
3. Canadian biomedical engineering pioneer receives international award
4. Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic
5. Canadian scientist mines drugs database for new diabetes treatment
6. First images from medical beamline at Canadian Light Source
7. Massive Canadian oilfield could be exploited using new UK system
8. Canadian Society of Exercise Physiology Annual Scientific Conference
9. Ancient organisms discovered in Canadian gold mine
10. First Science from the Compact Light Source: A miniature synchrotron for your home lab
11. Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...to understanding how sounds associated with Navy s...or if they hear it at all. , The same type of la... to detect flaws in the space shuttle,s behemoth s...ek inside the giant head of a whale. The scans are...a whale,s hearing anatomy using a breakthrough met...
(Date:11/24/2009)... Medical Toxicology (ACMT) have signed an agreemen...l of Medical Toxicology (JMT), the official journ...reviously published by the University of Pennsylva... , an international, peer-reviewed journal, is ded...dical toxicology. The quarterly journal focuses o...
(Date:11/24/2009)...New research on bacterial communities throughout s...le temporal patterns, suggesting that scientists c...ng climate change in the polar regions. The study,...tional Academy of Sciences Early Edition, shows t...d synchronously over time, correlating with season...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Potent metastasis inhibitor identified 49691 1Potent metastasis inhibitor identified 49691 2Lilly Declares Third Quarter Dividend 49687 1Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 49683 1Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 49683 2
... is closely tied to its sexual habits, ecologists ...olution of such intimate relationships between pla...f its kind and published online in the British Eco... helps explain the recent dramatic decline in cert... of species-rich chalk grasslands and hay meadows ...
... . , A study performed by researchers at the Ins... on the fruit fly, Drosophila melanogaster, unveil...neighboring cells in order to activate the cell pr...d growth of the fly wing. The signaling pathways ...ans, and when altered in diverse tissues give rise...
... may be more virulent than their close relatives b...research published in the May issue of the journal...stis needs calcium in order to grow at body temper...uces a large amount of an amino acid called aspart...ty of Chicago, USA. We found that this is because ...
Other Biology News:Ecologists tease out private lives of plants and their pollinators 2A study reveals how cells communicate to activate the cell division machinery 2
(Date:11/30/2009)...and LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCal...letin Board: CYXN; ,China Yongxin,Pharmaceuticals,...butor and,retailer of pharmaceuticals in Northeast...ation for distribution of medicines on the Essenti...cently formalized the nation,s Essential Drug,List...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- BioMarin Pharmaceutical I... and Drug Administration (FDA) has granted orphan ..., amifampridine phosphate, for the rare autoimmune... 3,4-DAP has previously received orphan drug desi...mmittee for Medicinal Products for Human Use of th...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...ts new class of platinum-based anti-tumor compound...anti-tumor potency and activity compared to curren...the ability to overcome cisplatin-resistance in ca...paper titled "Novel Bis-platinum Complexes Endowed...
(Date:11/30/2009)...30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: W...medical-device research and,development outsourcin...States,announced that it had been selected to the...he fifth consecutive year. The list recognizes the...y, media, and telecommunications,industries based ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2
...venue: $33.7 million, up 9% from $31.0 million in ...$10.5 million in Q1,08 , - Gross Margin: 21%, up f...al Distribution Agreement with Kimal plc , , LAWR... NXTM ), a leading manufacturer of innovative di...he first quarter of 2009 of $33.7 million, an incr...
...ence Pharmaceuticals, Inc. (Nasdaq: CADX ), a bi...eveloping and commercializing proprietary product ...ting, today reported financial results for the fir... completed the clinical development program for Ac...venous acetaminophen for the treatment of acute pa...
...ncorium Group, Inc. (Nasdaq: ENCO ), a full-ser...(CRO) that provides design, development, and manag... registries to many of the world,s leading pharmac...Hanna Nohynek, M.D., Ph.D. has been appointed Head...h team. , , Dr. Nohynek has an impressive track r...
Other Biology Technology:NxStage Reports First Quarter 2009 Financial Results 2NxStage Reports First Quarter 2009 Financial Results 3NxStage Reports First Quarter 2009 Financial Results 4NxStage Reports First Quarter 2009 Financial Results 5NxStage Reports First Quarter 2009 Financial Results 6NxStage Reports First Quarter 2009 Financial Results 7NxStage Reports First Quarter 2009 Financial Results 8NxStage Reports First Quarter 2009 Financial Results 9NxStage Reports First Quarter 2009 Financial Results 10NxStage Reports First Quarter 2009 Financial Results 11Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 2Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 3Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 4
Sentrix Custom-96 Expression Array Matrix (1) from Illumina
Mouse Anti-SERCA 1 ATPase Monoclonal Antibody, Unconjugated, Clone IIH11 from Novus Biologicals
AcroPrep 96 Filter Plates, 1 mL from Pall Life Sciences
HyQ SFX-Insect MP (1 x 5 L powder) from Hyclone
Biology Products: